Clear Street’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36K Sell
82,342
-100
-0.1% -$2 ﹤0.01% 1037
2025
Q4
$2.13K Sell
82,442
-200
-0.2% -$4 ﹤0.01% 848
2025
Q3
$1.69K Sell
82,642
-100
-0.1% -$2 ﹤0.01% 761
2025
Q2
$1.34K Buy
82,742
+100
+0.1% +$2 ﹤0.01% 600
2025
Q1
$3.31K Sell
82,642
-200
-0.2% -$12 ﹤0.01% 444
2024
Q4
$6.87K Sell
82,842
-200
-0.2% -$10 ﹤0.01% 382
2024
Q3
$3.23K Hold
83,042
﹤0.01% 504
2024
Q2
$3.23K Sell
83,042
-100
-0.1% -$6 ﹤0.01% 546
2024
Q1
$8.85K Buy
83,142
+100
+0.1% +$15 ﹤0.01% 441
2023
Q4
$14.4K Buy
83,042
+102
+0.1% +$10 ﹤0.01% 318
2023
Q3
$2.9K Hold
82,940
﹤0.01% 746
2023
Q2
$15.6K Sell
82,940
-4,167
-5% -$763 ﹤0.01% 624
2023
Q1
$27.9K Buy
+87,107
New +$20.4K ﹤0.01% 325

Other funds holding CDIOW

Clear Street's CDIOW Position: Q1 2026 in Review

Clear Street reduced its Cardio Diagnostics Holdings Inc Warrant (CDIOW) stake by 0.12% in Q1 2026, selling an estimated $2 and leaving 82,342 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Clear Street first reported a position in CDIOW in Q1 2023 and has held it in 13 quarters since. The position peaked at $27.9K in Q1 2023. 7 funds tracked by Wall St. Rank hold CDIOW as of Q1 2026.

  • Clear Street held 82,342 shares of Cardio Diagnostics Holdings Inc Warrant worth $1.36K as of Q1 2026.
  • Clear Street sold 100 Cardio Diagnostics Holdings Inc Warrant shares in Q1 2026, an estimated $2.
  • Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1037 holding.
  • Clear Street first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2023 and has held it in 13 quarters since.
  • Clear Street's Cardio Diagnostics Holdings Inc Warrant position peaked at $27.9K in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.